Russell Investments Group Ltd. Buys 251,482 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Russell Investments Group Ltd. increased its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 170.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 399,215 shares of the real estate investment trust's stock after acquiring an additional 251,482 shares during the period. Russell Investments Group Ltd. owned about 0.17% of Sabra Health Care REIT worth $5,697,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Tennessee Valley Asset Management Partners acquired a new position in Sabra Health Care REIT in the fourth quarter valued at about $25,000. GAMMA Investing LLC bought a new stake in Sabra Health Care REIT during the 4th quarter worth approximately $33,000. Signaturefd LLC grew its position in Sabra Health Care REIT by 45.2% during the 3rd quarter. Signaturefd LLC now owns 2,610 shares of the real estate investment trust's stock worth $36,000 after acquiring an additional 813 shares during the last quarter. Headlands Technologies LLC acquired a new stake in Sabra Health Care REIT during the 3rd quarter valued at $48,000. Finally, Harvest Fund Management Co. Ltd raised its position in Sabra Health Care REIT by 476.2% in the 4th quarter. Harvest Fund Management Co. Ltd now owns 4,425 shares of the real estate investment trust's stock valued at $63,000 after purchasing an additional 3,657 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Sabra Health Care REIT Trading Up 0.3 %

SBRA traded up $0.04 during midday trading on Friday, reaching $14.53. 1,772,835 shares of the company were exchanged, compared to its average volume of 2,036,540. The stock has a market capitalization of $3.36 billion, a P/E ratio of 289.80, a PEG ratio of 5.15 and a beta of 1.17. Sabra Health Care REIT, Inc. has a one year low of $10.30 and a one year high of $14.92. The stock's 50-day simple moving average is $14.15 and its 200 day simple moving average is $14.04. The company has a debt-to-equity ratio of 0.86, a quick ratio of 3.41 and a current ratio of 3.41.

Sabra Health Care REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Monday, May 20th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 8.26%. The ex-dividend date is Friday, May 17th. Sabra Health Care REIT's dividend payout ratio (DPR) is 2,400.00%.

Analyst Ratings Changes

SBRA has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft assumed coverage on Sabra Health Care REIT in a report on Tuesday, January 30th. They issued a "buy" rating and a $21.00 price target for the company. Wedbush reiterated an "outperform" rating and set a $17.00 target price on shares of Sabra Health Care REIT in a research report on Thursday, February 29th. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $15.77.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.